Steward Partners Investment Advisory, LLC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 72 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2
-90.5%
1000.0%0.00%
Q2 2023$21
+31.2%
1000.0%0.00%
Q1 2023$16
-71.4%
1000.0%0.00%
Q4 2022$561000.0%0.00%
Q3 2022$01000.0%0.00%
Q2 2022$01000.0%0.00%
Q1 2022$01000.0%0.00%
Q4 2021$01000.0%0.00%
Q3 2021$01000.0%0.00%
Q2 2021$0
-100.0%
100
-50.0%
0.00%
Q1 2021$646,000200
+100.0%
0.00%
Q4 2020$01000.0%0.00%
Q3 2020$01000.0%0.00%
Q2 2020$0
-100.0%
100
-93.8%
0.00%
Q1 2020$1,0000.0%1,6000.0%0.00%
Q4 2019$1,0000.0%1,6000.0%0.00%
Q3 2019$1,000
-50.0%
1,6000.0%0.00%
Q2 2019$2,000
-71.4%
1,600
-38.0%
0.00%
Q3 2018$7,000
+40.0%
2,5800.0%0.00%
Q2 2018$5,0000.0%2,5800.0%0.00%
Q1 2018$5,0000.0%2,5800.0%0.00%
Q4 2017$5,000
+400.0%
2,580
+163.3%
0.00%
Q3 2017$1,000
-50.0%
980
-27.5%
0.00%
Q2 2017$2,000
-50.0%
1,3520.0%0.00%
-100.0%
Q1 2017$4,0001,3520.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,354,963$38,132,0001.80%
Orbimed Advisors 4,520,800$73,201,0001.55%
QVT Financial LP 1,326,610$21,480,0001.44%
BB BIOTECH AG 1,089,828$17,646,0001.27%
Meditor Group Ltd 250,000$4,048,0000.55%
Perimeter Capital Partners, LLC 159,915$2,589,0000.50%
EMERALD MUTUAL FUND ADVISERS TRUST 156,808$2,539,0000.43%
Broadfin Capital, LLC 117,172$1,897,0000.37%
OXFORD ASSET MANAGEMENT LLP 811,331$13,184,0000.36%
Baker Brothers Advisors 1,016,433$16,458,0000.33%
View complete list of INFINITY PHARMACEUTICALS INC shareholders